Published in Am J Psychiatry on July 01, 2004
Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry (2008) 9.54
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2005) 3.92
Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry (2015) 3.56
The association between delusional-like experiences, and tobacco, alcohol or cannabis use: a nationwide population-based survey. BMC Psychiatry (2011) 1.54
Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity. Schizophr Bull (2008) 1.39
Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Res (2007) 1.32
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem Pharmacol (2007) 1.25
Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study. BMC Psychiatry (2008) 1.22
Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. Eur Arch Psychiatry Clin Neurosci (2010) 1.05
Smoking, Genetics and Schizophrenia: Evidence for Self Medication. J Dual Diagn (2007) 1.04
Substance abuse in patients with schizophrenia. Dialogues Clin Neurosci (2006) 1.02
Prevalence of cigarette smoking in schizophrenic patients compared to other hospital admitted psychiatric patients. Addict Health (2009) 1.01
Smoking and Schizophrenia in Population Cohorts of Swedish Women and Men: A Prospective Co-Relative Control Study. Am J Psychiatry (2015) 0.99
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) (2011) 0.99
Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci U S A (2012) 0.94
Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci (2006) 0.93
Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism. Neuropsychopharmacology (2011) 0.93
Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med (2014) 0.91
Nicotinic receptor gene CHRNA4 interacts with processing load in attention. PLoS One (2010) 0.88
Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.87
Effect of socioeconomic status and parents' education at birth on risk of schizophrenia in offspring. Soc Psychiatry Psychiatr Epidemiol (2008) 0.86
Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res (2011) 0.86
Association between psychiatric disorders and smoking stages within a representative clinic sample of Puerto Rican adolescents. Compr Psychiatry (2007) 0.85
Adult versus adolescent onset of smoking: how are mood disorders and other risk factors involved? Addiction (2009) 0.84
On blending practice and research: the search for commonalities in substance abuse treatment. Subst Abus (2006) 0.83
Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. PLoS One (2014) 0.81
Genetic Relationship between Schizophrenia and Nicotine Dependence. Sci Rep (2016) 0.80
Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. J Psychiatry Neurosci (2015) 0.79
Gender differences in the association between pre-adolescent smoking initiation and emotional or behavioural problems. BMC Public Health (2010) 0.79
Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology (Berl) (2005) 0.76
Progress in the Prospective Study of the Schizophrenia Prodrome. Curr Psychos Ther Rep (2005) 0.75
Biologic Commonalities between Mental Illness and Addiction. Prim psychiatry (2009) 0.75
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model. Biol Psychiatry (2016) 0.75
Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World J Psychiatry (2015) 0.75
Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia. Biol Psychiatry (2017) 0.75
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet (2008) 6.24
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91
Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry (2006) 4.77
Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med (2010) 4.42
Autism and mental retardation among offspring born after in vitro fertilization. JAMA (2013) 4.28
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
Advancing paternal age and autism. Arch Gen Psychiatry (2006) 3.58
A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet (2002) 3.52
Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol Psychiatry (2007) 3.42
Superresolution imaging using single-molecule localization. Annu Rev Phys Chem (2010) 3.30
Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med (2007) 3.18
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2008) 3.15
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Advancing paternal age and bipolar disorder. Arch Gen Psychiatry (2008) 2.56
Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry (2014) 2.51
Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull (2005) 2.20
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation (2002) 2.18
Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis (2005) 2.02
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2013) 1.96
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization. Schizophr Res (2006) 1.93
Identification of risk factors for infection in an outbreak of Mycoplasma pneumoniae respiratory tract disease. Clin Infect Dis (2006) 1.92
Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain (2007) 1.91
Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A (2010) 1.85
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull (2008) 1.81
Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry (2012) 1.76
Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry (2012) 1.73
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry (2002) 1.72
The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry (2002) 1.67
Season of birth, natural light, and myopia. Ophthalmology (2007) 1.65
Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med (2006) 1.61
The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry (2007) 1.57
Advanced paternal and grandpaternal age and schizophrenia: a three-generation perspective. Schizophr Res (2011) 1.57
Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci (2005) 1.55
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry (2005) 1.55
Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun (2005) 1.53
Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry (2010) 1.52
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res (2003) 1.51
Prevalence of celiac disease in an adult Jewish population in Israel. Isr Med Assoc J (2010) 1.45
Increased risk of attempted suicide among aging holocaust survivors. Am J Geriatr Psychiatry (2005) 1.45
The changing prevalence of myopia in young adults: a 13-year series of population-based prevalence surveys. Invest Ophthalmol Vis Sci (2005) 1.44
Clinical and epidemiologic investigation of two Legionella-Rickettsia co-infections. Isr Med Assoc J (2003) 1.44
A genetic and epidemiologic study of cardiovascular disease in Alaska natives (GOCADAN): design and methods. Int J Circumpolar Health (2005) 1.43
Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr Genet (2005) 1.42
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2002) 1.41
School-based obesity prevention programs: a meta-analysis of randomized controlled trials. Obesity (Silver Spring) (2013) 1.41
Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy. Menopause (2002) 1.41
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry (2004) 1.41
What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull (2008) 1.38
Trends in reproductive health in Israel: implications for environmental health policy. Isr J Health Policy Res (2012) 1.38
Low levels of circulating inflammatory cytokines--do they affect human brain functions? Brain Behav Immun (2002) 1.38
Preterm birth and psychiatric disorders in young adult life. Arch Gen Psychiatry (2012) 1.38
Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry (2012) 1.35
Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol (2005) 1.35
Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation (2005) 1.34
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry (2005) 1.34
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry (2005) 1.34
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res (2012) 1.33
Decrease in suicide rates after a change of policy reducing access to firearms in adolescents: a naturalistic epidemiological study. Suicide Life Threat Behav (2010) 1.33
Reliability of self-reported smoking history and age at initial tobacco use. Prev Med (2005) 1.32
Human vulnerability to stress depends on amygdala's predisposition and hippocampal plasticity. Proc Natl Acad Sci U S A (2009) 1.32
Tackling the next influenza pandemic. BMJ (2004) 1.32
Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Public Health (2011) 1.32
Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew. Int J Geriatr Psychiatry (2003) 1.31
NMII forms a contractile transcellular sarcomeric network to regulate apical cell junctions and tissue geometry. Curr Biol (2013) 1.29
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation (2005) 1.29
Thirty years of HIV in Israel: current epidemiology and future challenges. BMJ Open (2013) 1.26
Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res (2003) 1.26
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Clin Ther (2008) 1.25
Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. Br J Psychiatry (2010) 1.24
Cardiovascular disease among Alaska Natives: a review of the literature. Int J Circumpolar Health (2003) 1.23
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia. Am J Cardiol (2007) 1.22
A health in all policies approach to promote active, healthy lifestyle in Israel. Isr J Health Policy Res (2013) 1.21
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Advancing paternal age is associated with deficits in social and exploratory behaviors in the offspring: a mouse model. PLoS One (2009) 1.19
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol (2006) 1.17
The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. Eur Child Adolesc Psychiatry (2014) 1.16
Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians: the Strong Heart Study. Circulation (2004) 1.16
COMT: a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2004) 1.15